This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Checking in with a prescriber of Zurzuvae (zuranolone) for the treatment of postpartum depression.

Ticker(s): SAGE

Who's the expert?

Institution: University of Texas Houston Medical Center

  • Board certified in both female pelvic medicine and reconstructive surgery and obstetrics and gynecology.
  • Currently manages 60 patients for postpartum depression and has prescribed ZURZUVAE to 15 patients
  • Has been practicing in the Houston area since 2005 treating women 18 years and older and her primary clinical interests are pelvic floor disorders, urinary incontinence and pelvic organ prolapse. 

Interview Goal
This call will discuss the rollout of Zurzuvae and will include a prescriber's thoughts and opinions so far on this product.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.